For the first time, a beta blocker has been surpassed by another classof antihypertensive drug for the prevention of cardiovascular events inpatients with hypertension.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

ARB outperforms beta blocker for event prevention in hypertensives

Newsletter